Enanta Pharmaceuticals
ENTA
ENTA
148 hedge funds and large institutions have $956M invested in Enanta Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 54 increasing their positions, 57 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
-3
Holders Change %
-1.99%
% of All Funds
2.61%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
13
Increased
54
Reduced
57
Closed
15
Calls
$1.29M
Puts
$5.39M
Net Calls
-$4.1M
Net Calls Change
-$586K
Top Buyers
| 1 |
1
Northern Trust
Chicago,
Illinois
|
$31.8M |
| 2 |
2
BlackRock
New York
|
$184M |
| 3 |
AC
3
Armistice Capital
New York
|
$81.3M |
| 4 |
FCM
4
Farallon Capital Management
San Francisco,
California
|
$98.4M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$93.6M |
Top Sellers
| 1 |
1
Invesco
Atlanta,
Georgia
|
$16.1M |
| 2 |
2
First Manhattan
New York
|
$0 |
| 3 |
3
Millennium Management
New York
|
$1.18M |
| 4 |
4
Man Group
London,
United Kingdom
|
$0 |
| 5 |
5
Renaissance Technologies
New York
|
$44.4M |
